Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems

Statistical Power Analysis for the Behavioral Sciences

Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,588 · see citing works

The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication

Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · see citing works

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder [published erratum appears in Am J Psychiatry 1993 Aug;150(8):1280]

(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.885 · Cited by 1,421 · see citing works

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus

Viskochil, D. H., Buchberg, A. M., Xu, G., Cawthon, R., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082 · see citing works

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1

Hyman, S. L., Shores, E. A., & North, K. N. (2005) · Neurology · doi:10.1212/01.wnl.0000179303.72345.ce · Cited by 637 · see citing works

Prevalence of Neurofibromatosis 1 in German Children at Elementary School Enrollment

Lammert, M., Friedman, J. M., Kluwe, L., & Mautner, V. F. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.1.71 · Cited by 417 · see citing works

Treatment of ADHD in neurofibromatosis type 1

Mautner, V., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2002.tb00780.x · Cited by 250 · see citing works

Reliabilität und Validität der Wender-Utah-Rating-Scale-Kurzform: Retrospektive Erfassung von Symptomen aus dem Spektrum der Aufmerksamkeitsdefizit/Hyperaktivitätsstörung

Retz-Junginger, P., Retz, W., Blocher, D., Stieglitz, R.-D., Georg, T., Supprian, T., Wender, P. H., & Rösler, M. (2003) · Der Nervenarzt · doi:10.1007/s00115-002-1447-4 · Cited by 233 · see citing works

Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis

Woodruff, J. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1 · Cited by 229 · see citing works

Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit–hyperactivity disorder

Hyman, S. L., Shores, E. A., & North, K. N. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206002131 · Cited by 226 · see citing works

Quality-of-Life Impairment in Neurofibromatosis Type 1

Wolkenstein, P., Zeller, J., Revuz, J. E., Écosse, E., & Leplège, A. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.11.1421 · Cited by 207 · see citing works

Intellectual impairment in neurofibromatosis 1

Ferner, R. E., Hughes, R. A., & Weinman, J. A. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00022-6 · Cited by 184 · see citing works

Social skills of children with neurofibromatosis type 1

Barton, B., & North, K. N. (2004) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162204000921 · Cited by 178 · see citing works

Assessment of executive function and attention in children with neurofibromatosis type 1: Relationships between cognitive measures and real-world behavior

Payne, J. M., Hyman, S. L., Shores, E. A., & North, K. N. (2011) · Child Neuropsychology · doi:10.1080/09297049.2010.542746 · Cited by 157 · see citing works

Impact of neurofibromatosis 1 on Quality of Life: A cross‐sectional study of 176 American cases

Page, P. Z., Page, G. P., Écosse, E., Korf, B. R., Leplège, A., & Wolkenstein, P. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31422 · Cited by 151 · see citing works

The relationship between satisfaction with life, ADHD symptoms, and associated problems among university students

Gudjonsson, G. H., Sigurdsson, J. F., Smari, J., & Young, S. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708323018 · Cited by 149 · see citing works

Impact of Neurofibromatosis Type 1 on School Performance

Krab, L. C., Aarsen, F. K., de Goede-Bolder, A., Catsman‐Berrevoets, C. E., ARTS, W. F. M., Moll, H. A., & Elgersma, Y. (2008) · Journal of Child Neurology · doi:10.1177/0883073808316366 · Cited by 141 · see citing works

Children and Adolescents with Neurofibromatosis 1

Dilts, C., Carey, J. C., Kircher, J. C., Hoffman, R. O., Creel, D. J., Ward, K. J., Clark, E., & Leonard, C. O. (1996) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199608000-00004 · Cited by 136 · see citing works

Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1

Graf, A., Landolt, M. A., Mori, A. C., & Boltshauser, E. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.04.025 · Cited by 130 · see citing works

Social, emotional, and behavioral functioning of children with NF1

Noll, R. B., Reiter‐Purtill, J., Moore, B. D., Schorry, E. K., Lovell, A. M., Vannatta, K. A., & Gerhardt, C. A. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31923 · Cited by 130 · see citing works

Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1

Hyman, S. L., Gill, D. S., Shores, E. A., Steinberg, A., Joy, P., Gibikote, S., & North, K. N. (2003) · Neurology · doi:10.1212/01.wnl.0000055090.78351.c1 · Cited by 119 · see citing works

Association of attention deficit hyperactivity disorder-related psychopathology and personality traits with the serotonin transporter promoter region polymorphism

Retz, W., Thome, J., Blocher, D., Baader, M., & Rösler, M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02575-7 · Cited by 88 · see citing works

Does Cognitive Impairment Explain Behavioral and Social Problems of Children with Neurofibromatosis Type 1?

Huijbregts, S. C. J., & de Sonneville, L. M. J. (2010) · Behavior Genetics · doi:10.1007/s10519-010-9430-5 · Cited by 83 · see citing works

Relationship of attention‐deficit–hyperactivity disorder symptoms, depressive/anxiety symptoms, and life quality in young men

Chao, C.-Y., Gau, S., Mao, W.-C., Shyu, J., Chen, Y.-C., & Yeh, C. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01830.x · Cited by 74 · see citing works

Learning Disability Subtypes in Children with Neurofibromatosis

Brewer, V. R., Moore, B. D., & Hiscock, M. (1997) · Journal of Learning Disabilities · doi:10.1177/002221949703000508 · Cited by 68 · see citing works

Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases

Wolkenstein, P., Rodriguez, D., Ferkal, S., Gravier, H., Buret, V., Algans, N., Siméoni, M. C., & Bastuji‐Garin, S. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08949.x · Cited by 66 · see citing works

Beck Depression Inventory-II Items Associated With Self-Reported Symptoms of ADHD in Adult Psychiatric Outpatients

Steer, R. A., Ranieri, W. F., Kumar, G., & Beck, A. T. (2003) · Journal of Personality Assessment · doi:10.1207/s15327752jpa8001_14 · Cited by 37 · see citing works

Erfassung des hyperkinetischen Syndroms bei Erwachsenen

Gross, J., Blocher, D., Trott, G., & Rösler, M. (1999) · Der Nervenarzt · doi:10.1007/s001150050396 · Cited by 33 · see citing works

The Multiple Forms of Neurofibromatosis

Riccardi, V. M. (1982) · Pediatrics in Review · doi:10.1542/pir.3-9-293 · Cited by 30 · see citing works

Visibility of Neurofibromatosis 1 and Psychiatric Morbidity

Wolkenstein, P., Zeller, J., Revuz, J. E., Écosse, E., & Leplège, A. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.1.103 · Cited by 27 · see citing works

Neurofibromatosis type 1

Gutmann, D. H., Ferner, R. E., Listernick, R., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.4 · Cited by 870 · see citing works

Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

Stewart, D. R., Korf, B. R., Nathanson, K. L., Stevenson, D. A., & Yohay, K. H. (2018) · Genetics in Medicine · doi:10.1038/gim.2018.28 · Cited by 205 · see citing works

Worries and needs of adults and parents of adults with neurofibromatosis type 1

Rietman, A. B., van Helden, H., Both, P. H., Taal, W., Legerstee, J. S., van Staa, A., Moll, H. A., Oostenbrink, R., & van Eeghen, A. M. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38680 · Cited by 72 · see citing works

Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis

Merker, V. L., Bredella, M. A., Cai, W., Kassarjian, A., Harris, G. J., Muzikansky, A., Nguyen, R., Mautner, V. F., & Plotkin, S. R. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36466 · Cited by 62 · see citing works

The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults

Crawford, H., Barton, B., Wilson, M., Berman, Y. D., McKelvey‐Martin, V. J., Morrison, P. J., & North, K. N. (2015) · Journal of Genetic Counseling · doi:10.1007/s10897-015-9829-5 · Cited by 57 · see citing works

A randomized placebo‐controlled lovastatin trial for neurobehavioral function in neurofibromatosis I

Bearden, C. E., Hellemann, G., Rosser, T. L., Montojo, C. A., Jonas, R. K., Enrique, N., Pacheco, L., Hussain, S. A., Wu, J. Y., Ho, J. S., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.288 · Cited by 53 · see citing works

Sexual Function, Sexual Dysfunctions, and ADHD: A Systematic Literature Review

Soldati, L., Bianchi-Demicheli, F., Schockaert, P., Köhl, J., Bolmont, M., Hasler, R., & Perroud, N. A. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.03.019 · Cited by 42 · see citing works

Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis—Practice Resource of the National Society of Genetic Counselors

Radtke, H. B., Bergner, A. L., Goetsch, A. L., McGowan, C., Panzer, K., & Cannon, A. D. (2020) · Journal of Genetic Counseling · doi:10.1002/jgc4.1303 · Cited by 29 · see citing works

A rare disease and education: Neurofibromatosis type 1 decreases educational attainment

Johansson, E., Kallionpää, R. A., Böckerman, P., Peltonen, J. T. K., & Peltonen, S. A. (2020) · Clinical Genetics · doi:10.1111/cge.13907 · Cited by 24 · see citing works

‘It's like a bag of pick and mix – you don't know what you are going to get’: young people's experience of neurofibromatosis Type 1

Barke, J., Harcourt, D. M., & Coad, J. E. (2013) · Journal of Advanced Nursing · doi:10.1111/jan.12319 · Cited by 23 · see citing works

Conflict processing in juvenile patients with neurofibromatosis type 1 (NF1) and healthy controls – Two pathways to success

Bluschke, A., von der Hagen, M., Papenhagen, K., Roessner, V., & Beste, C. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.02.014 · Cited by 22 · see citing works

Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review

Miguel, C., Chaim, T., Silva, M. A., & Louzã, M. R. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75038 · Cited by 20 · see citing works

First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis

Talaei‐Khoei, M., Riklin, E. I. K., Merker, V. L., Sheridan, M. R., Jordan, J. T., Plotkin, S. R., & Vranceanu, A. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2314-7 · Cited by 20 · see citing works

Systematic Review and Meta-Analysis: Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Neurofibromatosis Type 1.

Hou, Y., Yu, L.-Y., Liu, D., Wilson-Lemoine, E., Wu, X., Moreira, J., Mujica, B. F., Mukhopadhyay, E. S., Novotney, A. N., & Payne, J. M. (2024) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1016/j.jaac.2024.09.011 · Cited by 3 · see citing works

Ventral striatum dopamine release encodes unique properties of visual stimuli in mice

Gonzalez, L. S., Fisher, A. A., D'Souza, S. P., Cotella, E. M., Lang, R. A., & Robinson, J. E. (2023) · eLife · doi:10.7554/elife.85064 · Cited by 18 · see citing works

Response inhibition in Attention deficit disorder and neurofibromatosis type 1 – clinically similar, neurophysiologically different

Bluschke, A., von der Hagen, M., Papenhagen, K., Roessner, V., & Beste, C. (2017) · Scientific Reports · doi:10.1038/srep43929 · Cited by 17 · see citing works

The Use of Drosophila to Understand Psychostimulant Responses

Philyaw, T. J., Rothenfluh, A., & Titos, I. (2022) · Biomedicines · doi:10.3390/biomedicines10010119 · Cited by 15 · see citing works

A new era for myelin research in N eurofibromatosis type 1

de Blank, P. M. K., Nishiyama, A., & López‐Juárez, A. (2023) · Glia · doi:10.1002/glia.24432 · Cited by 13 · see citing works

An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains

Smith, T. F., Kaczorowski, J. A., & Acosta, M. T. (2020) · Child s Nervous System · doi:10.1007/s00381-020-04745-w · Cited by 14 · see citing works

The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland

Johansson, E., Kallionpää, R. A., Böckerman, P., Peltonen, S. A., & Peltonen, J. T. K. (2021) · Genetics in Medicine · doi:10.1016/j.gim.2021.11.024 · Cited by 14 · see citing works

Uptake of health monitoring and disease self‐management in Australian adults with neurofibromatosis type 1: strategies to improve care

Crawford, H., Barton, B., Wilson, M., Berman, Y. D., McKelvey‐Martin, V. J., Morrison, P. J., & North, K. N. (2015) · Clinical Genetics · doi:10.1111/cge.12627 · Cited by 13 · see citing works

The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland

Kallionpää, R. A., Johansson, E., Böckerman, P., Peltonen, J. T. K., & Peltonen, S. A. (2023) · European Journal of Human Genetics · doi:10.1038/s41431-023-01426-5 · Cited by 10 · see citing works

Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1

Castricum, J., Tulen, J. H. M., Taal, W., Rietman, A. B., & Elgersma, Y. (2021) · Journal of Attention Disorders · doi:10.1177/10870547211012035 · Cited by 9 · see citing works

White matter is increased in the brains of adults with neurofibromatosis 1

Wang, S., Friedman, J. M., Suppa, P., Buchert, R., & Mautner, V. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02273-1 · Cited by 9 · see citing works

Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study

Doser, K., Jepsen, J. R. M., Kenborg, L., Miskowiak, K. W., Albieri, V., Dalton, S. O., Krøyer, A., Hove, H. D., Østergaard, J. R., Johansen, C., et al. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03454-w · Cited by 5 · see citing works

Lifelong Management of Neurofibromatosis 1 Patients

Chong, S. (2025) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2025.0057 · Cited by 5 · see citing works

Translational/Clinical Studies in Children and Adults with Neurofibromatosis Type 1

Korf, B. R., Widemann, B. C., Acosta, M. T., & Packer, R. J. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_40 · Cited by 5 · see citing works

Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation

Hernandez, D. P., Cruz, D. M. N., Martinez, C. S., Garcia, L. M., Figueroa, A., Villarreal, M., Manoj, L. M., Lopez, S., Lorenzo, K. D. L., & López‐Juárez, A. (2024) · Cancers · doi:10.3390/cancers16030477 · Cited by 4 · see citing works

Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1

Wilding, M., Fleming, J., Moore, K. M. H., Crook, A., Reddy, R., CHOI, S. E., Schlub, T. E., Field, M. J., Thiyagarajan, L., Thompson, J., et al. (2023) · Familial Cancer · doi:10.1007/s10689-023-00340-5 · Cited by 2 · see citing works

Recommendations of the Polish Sarcoma Group on diagnostic-therapeutic procedures and control in patients with type 1 neurofibromatosis (NF1) and the associated malignant neoplasm of peripheral nerve sheaths

Rutkowski, P. L., Raciborska, A., Szumera‐Ciećkiewicz, A., Sobczuk, P., Spalek, M. J., Koseła-Paterczyk, H., Lugowska, I. A., Bilska, K., Goś, M., Ryś, J., et al. (2022) · Nowotwory Journal of Oncology · doi:10.5603/njo.2022.0018 · Cited by 1 · see citing works

Cognitive Development and Learning in RASopathies

McNeill, A. M., Rogers, D. J., & Pierpont, E. I. (2024) · Springer eBooks · doi:10.1007/978-3-031-62945-7_26 · Cited by 1 · see citing works

A Systematic Review of Functional Brain Imaging Studies in Neurofibromatosis 1

Wild, A., Tziraki, M., Lea‐Carnall, C., & Garg, S. (2026) · Neuropsychology Review · doi:10.1007/s11065-026-09695-9 · Cited by 1 · see citing works

Social and Behavioural Research in Clinical Genetics

Tibben, A., Rigter, T., Waisfisz, Q., & Henneman, L. (2011) · Cited by 1 · see citing works

Learning Disabilities and Behaviour in Neurofibromatosis Type 1 Patients

Garg, S., & Green, J. (2020) · Springer eBooks · doi:10.1007/978-3-319-92450-2_14 · Cited by 1 · see citing works

Examining the cognitive phenotype in Neurofibromatosis 1: a systematic review of functional imaging studiesPreprint

Wild, A., Tziraki, M., Lea‐Carnall, C., & Garg, S. (2025) · medRxiv · doi:10.1101/2025.01.27.25321195

Diagnosis, Treatment, and Research Advances in Neurofibromatosis Type 1 Associated with Spinal Deformities

马, 志. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541225

Sexual experiences in patients with neurofibromatosis type 1: A cross-sectional study

van Dijk, S. A., Oldenmenger, W. H., Pastoor, H., & Taal, W. (2025) · Neuro-Oncology Practice · doi:10.1093/nop/npaf116

Additional file 1 of White matter is increased in the brains of adults with neurofibromatosis 1

Wang, S., Friedman, J. M., Suppa, P., Buchert, R., & Mautner, V.-F. (2022) · Figshare · doi:10.6084/m9.figshare.19313689

Managing Plexiform Neurofibroma and Other Complications of Neurofibromatosis Type 1 in the Adult Neurology Clinic

Schulte, J. D., Brown, R. M., Lala, N., Murthy, N. K., Raju, G. P., Mitchell, J. A., & Yohay, K. H. (2026) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200662

A – 47 Non-Inherited Neurofibromatosis Type 1 and Comorbid Attention-Deficit/Hyperactivity Disorder (ADHD): A Longitudinal Neuropsychological Profile from Childhood to Early Adulthood

Lapitan-Moore, F., & Baker, C. (2025) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaf084.070

Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se

Lion‐François, L., Herbillon, V., Peyric, E., Mercier, C., Gérard, D., Ginhoux, T., Coutinho, V., Kemlin, I., Kassaï, B., Portes, V. D., et al. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717707579 · Cited by 13 · see citing works

Neurofibromatosis tipo 1 y trastorno por déficit de atención. Nuestra experiencia actual

Marco, S. B. S., Pisón, J. L., Serrano-Viñuales, I., de Garayalde, L. T. F., Hidalgo, M. L., & Galindo, L. M. (2019) · Revista de Neurología · doi:10.33588/rn.6801.2018284 · Cited by 2 · see citing works

Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1

Payne, J. M., Haebich, K. M., MacKenzie, R., Walsh, K. S., Hearps, S. J. C., Coghill, D., Barton, B., Pride, N. A., Ullrich, N. J., Tonsgard, J. H., et al. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719894384 · Cited by 58 · see citing works

Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review

Miguel, C., Chaim, T., Silva, M. A., & Louzã, M. R. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75038 · Cited by 20 · see citing works